Status:
UNKNOWN
Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease
Lead Sponsor:
Complexo Hospitalario Universitario de A Coruña
Conditions:
Myocardial Infarction
Angioplasty, Transluminal, Percutaneous Coronary
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Multivessel disease has been reported to occur between 40 and 60% of patients with ST-segment elevation myocardial infarction (STEMI) and has been associated to a worse prognosis. Multivessel revascul...
Eligibility Criteria
Inclusion
- Typical chest pain lasting \>30 minutes with ST-segment elevation \>=1mm in \>=2 contiguous ECG leads or left bundle branch block and presentation \< 48 hours since symptom onset.
- Patients undergoing rescue PCI
- Patients with effective lysis and coronary angiography in less than 24 hours
- Presence of other lesion \>=70% in a non-culprit artery.
- Informed consent
Exclusion
- Significant left main disease
- Lesions in vessels \< 2 mm
- Lesions in branches of a main epicardial coronary artery and short irrigation territory
- Previous coronary artery bypass graft (CABG)
- Any coronary intervention in the previous month
- Cardiogenic shock
- Anatomic features no suitable for coronary intervention
- Pregnancy
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01179126
Start Date
September 1 2010
Last Update
September 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Complejo Hospitalario Universitario A Coruna
A Coruña, A Coruna, Spain, 15006